3
Participants
Start Date
July 30, 2017
Primary Completion Date
January 30, 2018
Study Completion Date
January 30, 2018
Cyclophosphamide
"The chemotherapy drugs will be given in the hospital. During the first cycle of treatment, participants will stay in the hospital until their blood counts have recovered after treatment. During cycles 2 and 3, participants may go home after chemotherapy if they are doing well. The length of each cycle is 28 days~\- Via IV Day 3"
Alemtuzumab
"* The chemotherapy drugs will be given in the hospital. During the first cycle of treatment, participants will stay in the hospital until their blood counts have recovered after treatment. During cycles 2 and 3, participants may go home after chemotherapy if they are doing well. The length of each cycle is 28 days~* Alemtuzumab will be administered as follows:~ * IV Day 1~ * IV Day 2~ * Target dose IV on Day 3 and 4"
Brigham and Women's Hospital, Boston
Dana Farber Cancer Institute, Boston
Collaborators (1)
Genzyme, a Sanofi Company
INDUSTRY
Sanofi
INDUSTRY
Dana-Farber Cancer Institute
OTHER